CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- D Other Notice of Sales of Unregistered Securities
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Conversion Director acquired 80,000 shares (conversion)
- 4 Conversion Chief Financial Officer acquired 10,000 shares (conversion)
- 4 Conversion Director acquired 1,500,000 shares (conversion)
- SCHEDULE 13D Stake Beneficial Ownership Report
- 4 Conversion 10% owner acquired 1,500,000 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Other events
Page 6 of 13 · 259 filings